Search results
Results From The WOW.Com Content Network
[2] [16] Following a study published by The Lancet on safety concerns with hydroxychloroquine, the WHO suspended use of it from the Solidarity trial in May 2020, [197] [198] reinstated it after the research was retracted, [199] then abandoned further use of the drug for COVID-19 treatment when analysis showed in June that it provided no benefit ...
The National Institutes of Health (NIH) COVID-19 Treatment Guidelines states "there is insufficient evidence to recommend either for or against the use of zinc for the treatment of COVID-19" and that "the Panel recommends against using zinc supplementation above the recommended dietary allowance for the prevention of COVID-19, except in a ...
[52] [53] [54] As of July 2021, a large number of drugs had been considered for treating COVID-19 patients. [55] As of November 2022, there was moderate-certainty evidence suggesting that dexamethasone, and systemic corticosteroids in general, probably cause a slight reduction in all-cause mortality (up to 30 days) in hospitalized patients with ...
Fresh studies give more information about what treatments do or don’t work for COVID-19, with high-quality methods that give reliable results.
The Solidarity trial for treatments is a multinational Phase III-IV clinical trial organized by the World Health Organization (WHO) and partners to compare four untested treatments for hospitalized people with severe COVID-19 illness.
Both treatments are for individuals that have mild to moderate COVID-19 symptoms in the last five days and are at a higher risk of getting more serious reactions.
Although not statistically significant, among these vaccinated participants, there was a reduction in the risk of COVID‑19 related hospitalization or death from any cause. [14] In December 2021, nirmatrelvir/ritonavir was granted emergency use authorization by the United States Food and Drug Administration (FDA) for the treatment of COVID ...
Scientists are testing existing drugs for their effects on COVID-19, but there's still a long road before they can be used to treat the virus. Why cheap, older drugs that might treat COVID never ...